Endothelial cell infection and hemostasis

Thrombosis Research

Volumn 119, Issue 5, 2007, Pages 531-549

  Sahni, Sanjeev K ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bacteria; Infection; Pathogenesis; Signal transduction; Vascular endothelium; Virus

Indexed keywords

ANAPLASMA PHAGOCYTOPHILUM; ARENAVIRUS; BACTERIAL INFECTION; BACTERIAL STRAIN; BARTONELLA; CELL INTERACTION; CHLAMYDIA; CITROBACTER FREUNDII; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; HANTAVIRUS; HEMOSTASIS; HOST CELL; HUMAN; LISTERIA; NONHUMAN; ORIENTIA; PATHOGENESIS; PATHOGENICITY; PLANT GROWTH; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION; VIRUS INFECTION;

ANIMALS; BACTERIA; ENDOTHELIAL CELLS; HEMOSTASIS; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION; VIRUSES;

EID: 33847216826     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.06.006     Document Type: Review

References (262)

1. Aird W.C. Endothelium as an organ system. Crit Care Med 32 (2004) S271-S279
2. Pasyk K.A., and Jakobczak B.A. Vascular endothelium: recent advances. Eur J Dermatol 14 (2004) 209-213
3. Tslotou A.G., Sakorafas G.H., Anagnostopoulos G., and Bramis J. Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit 11 (2005) RA76-RA85
4. Grandel U., and Grimminger F. Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol 23 (2003) 267-299
5. Broman M.T., and Malik A.B. Cellular and molecular biology for intensivists: a primer-endothelial cells. Crit Care Med 33 (2005) S517-S519
6. Crone C., and Oleson S.P. Electrical resistance of brain microvessel endothelium. Brain Res 241 (1992) 49-55
7. Reese T.S., and Karnovsky M.J. Fine structural localization of blood-brain barrier to exogenous peroxidase. J Cell Biol 34 (1967) 9-14
8. Vorbrodt A.W. Ultrastructural cytochemistry of blood-brain barrier endothelia. Prog Histochem Cytochem 18 (1988) 1-99
9. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561
10. Vercellotti G.M. Proinflammatory and procoagulant effects of herpes simplex infection on human endothelium. Blood Cells 16 (1990) 209-216
11. Van Dam-Mieras M.C.E., Muller A.D., van Hinsbergh V.W.M., Mullers W.J.H.A., Bomans P.H.H., and Bruggeman C.A. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 68 (1992) 364-370
12. Visseren F.L.J., Bouwman J.J.M., Bouter K.P., Diepersloot R.J.A., deGroot Ph.G., and Erkelens D.W. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 84 (2000) 319-324
13. Kim Y.C., Bang D., Lee S., and Lee K.H. The effect of herpesvirus infection on the expression of cell adhesion molecules on cultured human dermal microvascular endothelial cells. J Dermatol Sci 24 (2000) 38-47
14. Lafrenie R.M., Wahl L.M., Epstein J.S., Yamada K.M., and Dhawan S. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol 159 (1997) 4077-4083
15. Seigneur M., Constans J., Blann A., Renard M., Pellegrin J.L., Admiral J., et al. Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost 77 (1997) 646-649
16. Kanmogne G.D., Primeaux C., and Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 64 (2005) 498-505
17. 3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25 (2005) 2315-2320
18. Peters C.J., and Zaki S.R. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 30 (2002) S268-S273
19. Schnittler H.J., and Feldmann H. Viral hemorrhagic fever - a vascular disease?. Thromb Haemost 89 (2003) 967-972
20. Eremeeva M.E., Dasch G.A., and Silverman D.J. Interaction of rickettsiae with eukaryotic cells. Adhesion, entry, intracellular growth, and host cell responses. Subcell Biochem 33 (2000) 479-516
21. Walker D.H. Ricketts creates rickettsiology, the study of vector-borne obligately intracellular bacteria. J Infect Dis 189 (2004) 938-955
22. Seong S.Y., Choi M.S., and Kim I.S. Orientia tsutsugamushi infection: overview and immune responses. Microbes Infect 3 (2001) 11-21
23. Popov V.L., Feng H.M., Wear D., and Walker D.H. Identification of the target cells of Orientia tsutsugamushi in human cases of scrub typhus. Mod Pathol 14 (2001) 752-759
24. Munderloh U.G., Lynch M.J., Herron M.J., Palmer A.T., Kurtti T.J., Nelson R.D., et al. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet Microbiol 101 (2004) 53-64
25. Herron M.J., Ericson M.E., Kurtti T.J., and Munderloh U.G. The interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. Ann N Y Acad Sci 1063 (2005) 374-382
26. Dehio C. Interactions of Bartonella henselae with vascular endothelial cells. Curr Opin Microbiol 2 (1999) 78-82
27. Greub G., and Raoult D. Bartonella: new explanations for old diseases. J Med Microbiol 51 (2002) 915-923
28. Summersgill J.T., Molestina R.E., Miller R.D., and Ramirez J.A. Interactions of Chlamydia pneumoniae with human endothelial cells. J Infect Dis 181 (2000) S479-S482
29. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae pathogenesis. J Med Microbiol 51 (2002) 623-625
30. Zhu C., Ghabriel M.N., Blumbergs P.C., Reilly P.L., Manavis J., Youssef J., et al. Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol 169 (2001) 72-82
31. Bryant A.E. Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A Streptococci and Clostridium perfringens. Clin Microbiol Rev 16 (2003) 451-462
32. Drevets D.A., Sawyer R.T., Potter T.A., and Campbell P.A. Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun 63 (1995) 4268-4276
33. Greiffenberg L., Goebel W., Kim K.S., Daniels J., and Kuhn M. Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: an electron microscopic study. Infect Immun 68 (2000) 3275-3279
34. Eugene E., Hoffmann I., Pujol C., Couraud P.O., Bourdoulous S., and Nassif X. Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J Cell Sci 115 (2002) 1231-1241
35. Sokolova O., Heppel N., Jagerhuber R., Kim K.S., Frosch M., Eigenthaler M., et al. Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell Microbiol 6 (2004) 1153-1166
36. Kuramitsu H.K., Miyakawa H., Qi M., and Kang I.C. Cellular responses to oral pathogens. Ann Periodontol 7 (2002) 90-94
37. Chou H.H., Yumoto H., Davey M., Takahashi Y., Miyamoto T., Gibson III F.C., et al. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun 73 (2005) 5367-5378
38. Gibson R.L., Soderland C., Henderson Jr. W.R., Chi E.Y., and Rubens C.E. Group B Streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun 63 (1995) 271-279
39. Vernier A., Diab M., Soell M., Haan-Archipoff G., Beretz A., Wachsmann D., et al. Cytokine production by human epithelial and endothelial cells following exposure to oral viridans Streptococci involves lectin interactions between bacteria and cell surface receptors. Infect Immun 64 (1996) 3016-3022
40. Bryant A.E., Hayes-Schroer S.M., and Stevens D.L. M type 1 and 3 group A Streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells. Infect Immun 71 (2003) 1903-1910
41. Stinson M.W., Alder S., and Kumar S. Invasion and killing of human endothelial cells by viridans group Streptococci. Infect Immun 71 (2003) 2365-2372
42. Cheung A.L., Krishnan M., Jaffe E.A., and Fischetti V.A. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest 87 (1991) 2236-2245
43. Menzies B.E., and Kourteva I. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immun 66 (1998) 5994-5998
44. Schroten H., Spors B., Hucke C., Stins M., Kim K.S., Adam R., et al. Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 32 (2001) 206-210
45. Walker D.H. Endothelial-target rickettsial infection. Lab Anim Sci 47 (1997) 483-485
46. Billings A.N., Feng H.M., Olano J.P., and Walker D.H. Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon. Am J Trop Med Hyg 65 (2001) 52-56
47. Valbuena G., Bradford W., and Walker D.H. Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by Rickettsiae of the spotted fever group. Am J Pathol 163 (2003) 1357-1369
48. Valbuena G., Jordan J.M., and Walker D.H. T cells mediate cross-protective immunity between spotted fever group Rickettsiae and typhus group Rickettsiae. J Infect Dis 190 (2004) 1221-1227
49. Yotsukura M., Aoki N., Fukuzumi N., and Ishikawa K. Review of a case of tsutsugamushi disease showing myocarditis and confirmation of Rickettsia by endomyocardial biopsy. Jpn Circ J 55 (1991) 149-153
50. Cho N.H., Seong S.Y., Huh M.S., Kim N.H., Choi M.S., and Kim I.S. Induction of the gene encoding macrophage chemoattractant protein 1 by Orientia tsutsugamushi in human endothelial cells involves activation of transcription factor activator protein 1. Infect Immun 70 (2002) 4841-4850
51. Kim K.S. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 4 (2003) 376-385
52. Lossinsky A.S., and Shivers R.R. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Histol Histopathol 19 (2004) 535-564
53. Karch H., Tarr P.I., and Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295 (2005) 405-418
54. Kim K.S. E. coli invasion of brain microvascular endothelial cells as a pathogenetic basis of meningitis. Subcell Biochem 33 (2000) 47-59
55. Badger J.L., Stins M.F., and Kim K.S. Citrobacter freundii invades and replicates in human brain microvascular endothelial cells. Infect Immun 67 (1999) 4208-4215
56. Doran K.S., Engelson E.J., Khosravi A., Maisey H.C., Fedtke I., Equils O., et al. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 115 (2005) 2499-2507
57. Ring A., Weiser J.N., and Tuomanen E.I. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 102 (1998) 347-360
58. Grab D.J., Perides G., Dumler J.S., Kim K.J., Park J., Kim Y.V., et al. Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun 73 (2005) 1014-1022
59. Gerna G., Baldanti F., and Revello M.G. Pathogenesis of human cytomegalovirus infection and cellular targets. Hum Immunol 65 (2004) 381-386
60. Valbuena G., and Walker D.H. The endothelium as a target for infections. Annu Rev Pathol Mech Dis 1 (2006) 171-198
61. Vossen R.C., Derhaag J.G., Slobbe-van Drunen M.E., Duijvestijn A.M., van Dam-Mieras M.C., and Bruggeman C.A. A dual role for endothelial cells in cytomegalovirus infection? A study of cytomegalovirus infection in a series of rat endothelial cell lines. Virus Res 46 (1996) 65-74
62. Chen R., Xiong S., Yang Y., Fu W., Wang Y., and Ge J. The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem 249 (2003) 91-96
63. Nerheim P.L., Meier J.L., Vasef M.A., Li W.G., Hu L., Rice J.B., et al. Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol 164 (2004) 589-600
64. Lunardi C., Bason C., Corrocher R., and Puccetti A. Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol 26 (2005) 19-24
65. Carlson J.R., Chang W.L., Zhou S.S., Tarantal A.F., and Barry P.A. Rhesus brain microvascular endothelial cells are permissive for rhesus cytomegalovirus infection. J Gen Virol 86 (2005) 545-549
66. Rue C.A., Jarvis M.A., Knoche A.J., Meyers H.L., DeFilippis V.R., Hansen S.G., et al. A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol 78 (2004) 12529-12536
67. Brune W., Menard C., Heesemann J., and Koszinowski U.H. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291 (2001) 303-305
68. Lembo D., Donalisio M., Hofer A., Cornaglia M., Brune W., Koszinowski U., et al. The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol 78 (2004) 4278-4288
69. Rahbar A., and Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 79 (2005) 2211-2220
70. Reinhardt B., Schaarschmidt P., Bossert A., Luske A., Finkenzeller G., Mertens T., et al. Upregulation of functionally active vascular endothelial growth factor by human cytomegalovirus. J Gen Virol 86 (2005) 23-30
71. Schnittler H.J., Mahner F., Drenckhahn D., Klenk H.D., and Feldmann H. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 91 (1993) 1301-1309
72. Gibb T.R., Bray M., Geisbert T.W., Steele K.E., Kell W.M., Davis K.J., et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 125 (2001) 233-242
73. Geisbert T.W., Young H.A., Jahrling P.B., Davis K.J., Larsen T., Kagan E., et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163 (2003) 2371-2382
74. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305 (2003) 115-123
75. Harcourt B.H., Sanchez A., and Offermann M.K. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. J Virol 73 (1999) 3491-3496
76. Yang Z., Delgado R., Xu L., Todd R.F., Nabel E.G., Sanchez A., et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science 279 (1998) 1034-1037
77. Feldmann H., Volchkov V.E., Volchkova V.A., and Klenk H.D. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl 15 (1999) 159-169
78. Ray R.B., Basu A., Steele R., Beyene A., McHowat J., Meyer K., et al. Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells. Virology 321 (2004) 181-188
79. Wahl-Jensen V.M., Afanasieva T.A., Seebach J., Stroher U., Feldmann H., and Schnittler H.J. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 79 (2005) 10442-10450
80. Mori M., Rothman A.L., Kurane I., Montoya J.M., Nolte K.B., Norman J.E., et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179 (1999) 295-302
81. Bahr U., Muranyi W., Muller S., Kehm R., Handermann M., Darai G., et al. Bovine aortic endothelial cells are susceptible to hantaan virus infection. Virology 321 (2004) 1-7
82. Yanagihara R., and Silverman D.J. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol 111 (1990) 281-286
83. Cosgriff T.M. Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 13 (1991) 97-107
84. Geimonen E., Neff S., Raymond T., Kocer S.S., Gavrilovskaya I.N., and Mackow E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A 99 (2002) 13837-13842
85. Kraus A.A., Raftery M.J., Giese T., Ulrich R., Zawatzky R., Hippenstiel S., et al. Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol 78 (2004) 6143-6150
86. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., and Mackow E.R. β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A 95 (1998) 7074-7079
87. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., and Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins. J Virol 73 (1999) 3951-3959
88. Mackow E.R., and Gavrilovskaya I.N. Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 256 (2001) 91-115
89. Gavrilovskaya I.N., Peresleni T., Geimonen E., and Mackow E.R. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147 (2002) 1913-1931
90. Niikura M., Maeda A., Ikegami T., Saijo M., Kurane I., and Morikawa S. Modification of endothelial cell functions by hantaan virus infection: prolonged hyperpermeability induced by TNF-α of hantaan virus-infected endothelial cell monolayers. Arch Virol 149 (2004) 1279-1292
91. Ennis F.A., Cruz J., Spiropoulou C.F., Waite D., Peters C.J., Nichol S.T., et al. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238 (1997) 380-390
92. Khaiboullina S.F., Rizvanov A.A., Otteson E., Miyazato A., Maciejewski J., and St Jeor S. Regulation of cellular gene expression in endothelial cells by sin nombre and prospect hill viruses. Viral Immunol 17 (2004) 234-251
93. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146 (1995) 552-579
94. Flore O., Rafii S., Ely S., O'Leary J.J., Hyjek E.M., and Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394 (1998) 588-592
95. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 96 (1999) 4546-4551
96. Blackbourn D.J., Lennette E., Klencke B., Moses A., Chandran B., Weinstein M., et al. The restricted cellular host range of human herpesvirus 8. AIDS 14 (2000) 1123-1133
97. Cannon J.S., Ciufo D., Hawkins A.L., Griffin C.A., Borowitz M.J., Hayward G.S., et al. A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 74 (2000) 10187-10193
98. Yang T.Y., Chen S.C., Leach M.W., Manfra D., Homey B., Wiekowski M., et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191 (2000) 445-454
99. Hong Y.K., Foreman K., Shin J.W., Hirakawa S., Curry C.L., Sage D.R., et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36 (2004) 683-685
100. Carroll P.A., Brazeau E., and Lagunoff M. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 328 (2004) 7-18
101. Sgarbanti M., Arguello M., tenOever B.R., Battistini A., Lin R., and Hiscott J. A requirement for NF-κB induction in the production of replication-competent HHV-8 virions. Oncogene 23 (2004) 5770-5780
102. Chugh P., Matta H., Schamus S., Zachariah S., Kumar A., Richardson J.A., et al. Constitutive NF-κB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci U S A 102 (2005) 12885-12890
103. Xie J., Pan H., Yoo S., and Gao S.J. Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways. J Virol 79 (2005) 15027-15037
104. Pati S., Foulke Jr. J.S., Barabitskaya O., Kim J., Nair B.C., Hone D., et al. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol 77 (2003) 5759-5773
105. Masood R., Xia G., Smith D.L., Scalia P., Still J.G., Tulpule A., et al. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood 105 (2005) 1310-1318
106. Wang L., Wakisaka N., Tomlinson C.C., DeWire S.M., Krall S., Pagano J.S., et al. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res 64 (2004) 2774-2781
107. McAllister S.C., Hansen S.G., Ruhl R.A., Rago C.M., DeFilippis V.R., Greenspan D., et al. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103 (2004) 3465-3473
108. Marinissen M.J., Tanos T.T., Bolos M., de Sagarra M.R., Coso O.A., and Cuadrado A. Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. J Biol Chem 281 (2006) 11332-11346
109. Masood R., Cesarman E., Smith D.L., Gill P.S., and Flore O. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am J Pathol 160 (2002) 23-29
110. Bais C., Van Geelen A., Eroles P., Mutlu A., Chiozzini C., Dias S., et al. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3 (2003) 131-143
111. Zhang X., Wang J.F., Chandran B., Persaud K., Pytowski B., Fingeroth J., et al. Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. J Biol Chem 280 (2005) 26216-26224
112. Pan H., Zhou F., and Gao S.J. Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res 64 (2004) 4064-4068
113. Mohanty S., Bakshi S., Gupta A.K., Kapil A., Arya L.S., and Das B.K. Venous thrombosis associated with Salmonella: report of a case and review of literature. Indian J Med Sci 57 (2003) 199-203
114. Kim B.Y., Kang J., and Kim K.S. Invasion processes of pathogenic Escherichia coli. Int J Med Microbiol 295 (2005) 463-470
115. Parola P., Paddock C.D., and Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 18 (2005) 719-756
116. Hackstadt T. The biology of Rickettsiae. Infect Agents Dis 5 (1996) 127-143
117. Elghetany M.T., and Walker D.H. Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever. Am J Clin Pathol 112 (1999) 159-168
118. Davidson M.G., Breitschwerdt E.B., Walker D.H., Levy M.G., Carlson C.S., Hardie E.M., et al. Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs. Am J Vet Res 51 (1990) 165-170
119. Schmaier A.H., Srikanth S., Elghetany M.T., Normolle D., Gokhale S., Feng H.M., et al. Hemostatic/fibrinolytic protein changes in C3H/HeN mice infected with Rickettsia conorii - a model for Rocky Mountain spotted fever. Thromb Haemost 86 (2001) 871-879
120. Vicente V., Estellés A., Moraleda J.M., España F., and Aznar J. Fibrinolytic changes during acute vascular damage induced by Mediterranean spotted fever. Fibrionolysis 7 (1993) 324-329
121. Rao A.K., Schapira M., Clements M.L., Niewiarowski S., Budzynski A.Z., Schmaier A.H., et al. A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med 318 (1988) 1021-1028
122. Vicente V., Espana F., Tabernero D., Estelles A., Aznar J., Hendl S., et al. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever. Blood 78 (1991) 416-422
123. Yamada T., Harber P., Pettit G.W., Wing D.A., and Oster C.N. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. Ann Intern Med 88 (1978) 764-768
124. Vicente V., Alegre A., Ruiz R., Herrero J.I., Portugal J., and Alberca I. Kininprekallikrein system in Mediterranean spotted fever. J Infect Dis 154 (1986) 541
125. Vicente V., Alberca I., Ruiz R., Herrero I., Gonzalez R., and Portugal J. Coagulation abnormalities in patients with Mediterranean spotted fever. J Infect Dis 153 (1986) 128-131
126. George F., Brouqui P., Boffa M.C., Mutin M., Drancourt M., Brisson C., et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 82 (1993) 2109-2116
127. Davi G., Giammarresi C., Vigneri S., Ganci A., Ferri C., Di Francesco L., et al. Demonstration of Rickettsia conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. Thromb Haemost 74 (1995) 631-634
128. Davi G., Giammarresi C., Vitale G., and Mansueto S. Enhanced thromboxane biosynthesis in patients with Mediterranean spotted fever. Blood 83 (1994) 3101
129. Sporn L.A., Shi R.J., Lawrence S.O., Silverman D.J., and Marder V.J. Rickettsia rickettsii infection of cultured endothelial cells induces release of large von Willebrand factor multimers from Weibel-Palade bodies. Blood 78 (1991) 2595-2602
130. Teysseire N., Arnoux D., George F., Sampol J., and Raoult D. von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells. Infect Immun 60 (1992) 4388-4393
131. Sporn L.A., Lawrence S.O., Silverman D.J., and Marder V.J. E-selectin-dependent neutrophil adhesion to Rickettsia rickettsii-infected endothelial cells. Blood 81 (1993) 2406-2412
132. Dignat-George F., Teysseire N., Mutin M., Bardin N., Lesaule G., Raoult D., et al. Rickettsia conorii infection enhances vascular cell adhesion molecule-1- and intercellular adhesion molecule-1-dependent mononuclear cell adherence to endothelial cells. J Infect Dis 175 (1997) 1142-1152
133. Sahni S.K., Turpin L.C., Brown T.L., and Sporn L.A. Involvement of protein kinase C in Rickettsia rickettsii-induced transcriptional activation of the host endothelial cell. Infect Immun 67 (1999) 6418-6423
134. Valbuena G., and Walker D.H. Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections. Am J Trop Med Hyg 71 (2004) 393-399
135. Kaplanski G., Teysseire N., Farnarier C., Kaplanski S., Lissitzky J.C., Durand J.M., et al. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1α-dependent pathway. J Clin Invest 96 (1995) 2839-2844
136. Valbuena G., and Walker D.H. Expression of CX3CL1 (fractalkine) in mice with endothelial-target rickettsial infection of the spotted-fever group. Virchows Arch 446 (2005) 21-27
137. Sporn L.A., and Marder V.J. Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation. Infect Immun 64 (1996) 1609-1613
138. Clifton D.R., Rydkina E., Huyck H., Pryhuber G., Freeman R.S., Silverman D.J., et al. Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-κB. Int J Med Microbiol 295 (2005) 267-278
139. Eremeeva M.E., and Silverman D.J. Rickettsia rickettsii infection of the EA.hy 926 endothelial cell line: morphological response to infection and evidence for oxidative injury. Microbiology 144 (1998) 2037-2048
140. Eremeeva M.E., Dasch G.A., and Silverman D.J. Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii. Clin Diagn Lab Immunol 8 (2001) 788-796
141. Eremeeva M.E., Liang Z., Paddock C., Zaki S., Vandenbergh J.G., Dasch G.A., et al. Rickettsia rickettsii infection in the pine vole, Microtus pinetorum: kinetics of infection and quantitation of antioxidant enzyme gene expression by RT-PCR. Ann N Y Acad Sci 990 (2003) 468-473
142. Rydkina E., Sahni A., Silverman D.J., and Sahni S.K. Rickettsia rickettsii infection of cultured human endothelial cells induces heme oxygenase 1 expression. Infect Immun 70 (2002) 4045-4052
143. Rydkina E., Sahni S.K., Santucci L.A., Turpin L.C., Baggs R.B., and Silverman D.J. Selective modulation of antioxidant enzyme activities in host tissues during Rickettsia conorii infection. Microb Pathog 36 (2004) 293-301
144. Sahni S.K., Rydkina E., Sahni A., Joshi S.G., and Silverman D.J. Potential roles for regulatory oxygenases in rickettsial pathogenesis. Ann N Y Acad Sci 1063 (2005) 207-214
145. Campbell L.A., and Kuo C.C. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis?. Nat Rev Microbiol 2 (2004) 23-32
146. Ezzahiri R., Stassen F.R., Kurvers H.R., Dolmans V., Kitslaar P.J., and Bruggeman C.A. Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P. APMIS 114 (2006) 117-126
147. Moazed T.C., Kuo C., Grayston J.T., and Campbell L.A. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175 (1997) 883-890
148. Moazed T.C., Kuo C.C., Grayston J.T., and Campbell L.A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177 (1998) 1322-1325
149. Gaydos C.A. Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 181 (2000) S473-S478
150. Hauer A.D., de Vos P., Peterse N., ten Cate H., van Berkel T.J., Stassen F.R., et al. Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice. Cardiovasc Res 69 (2006) 280-288
151. Coombes B.K., and Mahony J.B. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 69 (2001) 1420-1427
152. Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen K.S., Equils O., et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 168 (2002) 1435-1440
153. Tiran A., Gruber H.J., Graier W.F., Wagner A.H., Van Leeuwen E.B., and Tiran B. Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-κB activation, cytokine expression, and bacterial development in human endothelial cells. Arterioscler Thromb Vasc Biol 22 (2002) 1075-1080
154. Niessner A., Kaun C., Zorn G., Speidl W., Turel Z., Christiansen G., et al. Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-κB pathway. J Infect Dis 188 (2003) 108-113
155. Krull M., Kramp J., Petrov T., Klucken A.C., Hocke A.C., Walter C., et al. Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells. Infect Immun 72 (2004) 6615-6621
156. Prochnau D., Rodel J., Hartmann M., Straube E., and Figulla H.R. Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 294 (2004) 53-57
157. Coombes B.K., Chiu B., Fong I.W., and Mahony J.B. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J Infect Dis 185 (2002) 1621-1630
158. Opitz B., Forster S., Hocke A.C., Maass M., Schmeck B., Hippenstiel S., et al. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 96 (2005) 319-326
159. MacIntyre A., Hammond C.J., Little C.S., Appelt D.M., and Balin B.J. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiol Lett 217 (2002) 167-172
160. MacIntyre A., Abramov R., Hammond C.J., Hudson A.P., Arking E.J., Little C.S., et al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res 71 (2003) 740-750
161. Garcia F.U., Wojta J., Broadley K.N., Davidson J.M., and Hoover R.L. Bartonella bacilliformis stimulates endothelial cells in vitro and is angiogenic in vivo. Am J Pathol 136 (1990) 1125-1135
162. Arrese Estrada J., and Pierard G.E. Dendrocytes in verruga peruana and bacillary angiomatosis. Dermatology 184 (1992) 22-25
163. Bhutto A.M., Nonaka S., Hashiguchi Y., and Gomez E.A. Histopathological and electron microscopical features of skin lesions in a patient with bartonellosis (verruga peruana). J Dermatol 21 (1994) 178-184
164. Dehio C. Molecular and cellular basis of Bartonella pathogenesis. Annu Rev Microbiol 58 (2004) 365-390
165. Ihler G.M. Bartonella bacilliformis: dangerous pathogen slowly emerging from deep background. FEMS Microbiol Lett 144 (1996) 1-11
166. Anderson B.E., and Neuman M.A. Bartonella spp. as emerging human pathogens. Clin Microbiol Rev 10 (1997) 203-219
167. Riess T., Andersson S.G., Lupas A., Schaller M., Schafer A., Kyme P., et al. Bartonella adhesin A mediates a proangiogenic host cell response. J Exp Med 200 (2004) 1267-1278
168. Kirby J.E. In vitro model of Bartonella henselae-induced angiogenesis. Infect Immun 72 (2004) 7315-7317
169. Dehio C. Bartonella-host-cell interactions and vascular tumour formation. Nat Rev Microbiol 3 (2005) 621-631
170. Kirby J.E., and Nekorchuk D.M. Bartonella-associated endothelial proliferation depends on inhibition of apoptosis. Proc Natl Acad Sci U S A 99 (2002) 4656-4661
171. Liberto M.C., Matera G., Lamberti A.G., Barreca G.S., Quirino A., and Foca A. In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells. Diagn Microbiol Infect Dis 45 (2003) 107-115
172. Liberto M.C., Matera G., Lamberti A.G., Barreca G.S., Foca D., Quirino A., et al. Bartonella quintana-induced apoptosis inhibition of human endothelial cells is associated with p38 and SAPK/JNK modulation and with stimulation of mitosis. Diagn Microbiol Infect Dis 50 (2004) 159-166
173. Minnick M.F., Smitherman L.S., and Samuels D.S. Mitogenic effect of Bartonella bacilliformis on human vascular endothelial cells and involvement of GroEL. Infect Immun 71 (2003) 6933-6942
174. Smitherman L.S., and Minnick M.F. Bartonella bacilliformis GroEL: effect on growth of human vascular endothelial cells in infected cocultures. Ann N Y Acad Sci 1063 (2005) 286-298
175. Kempf V.A., Volkmann B., Schaller M., Sander C.A., Alitalo K., Riess T., et al. Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol 3 (2001) 623-632
176. Resto-Ruiz S.I., Schmiederer M., Sweger D., Newton C., Klein T.W., Friedman H., et al. Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection. Infect Immun 70 (2002) 4564-4570
177. Cerimele F., Brown L.F., Bravo F., Ihler G.M., Kouadio P., and Arbiser J.L. Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor. Am J Pathol 163 (2003) 1321-1327
178. Fuhrmann O., Arvand M., Gohler A., Schmid M., Krull M., Hippenstiel S., et al. Bartonella henselae induces NF-κB-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors. Infect Immun 69 (2001) 5088-5097
179. McCord A.M., Burgess A.W., Whaley M.J., and Anderson B.E. Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration. Infect Immun 73 (2005) 5735-5742
180. Schmid M.C., Schulein R., Dehio M., Denecker G., Carena I., and Dehio C. The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol Microbiol 52 (2004) 81-92
181. Kempf V.A., Lebiedziejewski M., Alitalo K., Walzlein J.H., Ehehalt U., Fiebig J., et al. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation 111 (2005) 1054-1062
182. Dehio M., Quebatte M., Foser S., and Certa U. The transcriptional response of human endothelial cells to infection with Bartonella henselae is dominated by genes controlling innate immune responses, cell cycle, and vascular remodelling. Thromb Haemost 94 (2005) 347-361
183. Chi W.C., Huang J.J., Sung J.M., Lan R.R., Ko W.C., and Chen F.F. Scrub typhus associated with multiorgan failure: a case report. Scand J Infect Dis 29 (1997) 634-635
184. Ben R.J., Feng N.H., and Ku C.S. Meningoencephalitis, myocarditis and disseminated intravascular coagulation in a patient with scrub typhus. Microbiol Immunol Infect 32 (1999) 57-62
185. Kodama K., Senba T., Yamauchi H., Chikahira Y., Katayama T., Furuya Y., et al. Fulminant Japanese spotted fever definitively diagnosed by the polymerase chain reaction method. J Infect Chemother 8 (2002) 266-268
186. Kim M.K., Kee S.H., Cho K.A., Chung M.H., Lim B.U., Chang W.H., et al. Apoptosis of endothelial cell line ECV304 persistently infected with Orientia tsutsugamushi. Microbiol Immunol 43 (1999) 751-757
187. Kee S.H., Cho K.A., Kim M.K., Lim B.U., Chang W.H., and Kang J.S. Disassembly of focal adhesions during apoptosis of endothelial cell line ECV304 infected with Orientia tsutsugamushi. Microb Pathog 27 (1999) 265-271
188. Cho N.H., Seong S.Y., Choi M.S., and Kim I.S. Expression of chemokine genes in human dermal microvascular endothelial cell lines infected with Orientia tsutsugamushi. Infect Immun 69 (2001) 1265-1272
189. Cho N.H., Seong S.Y., Huh M.S., Han T.H., Koh Y.S., Choi M.S., et al. Expression of chemokine genes in murine macrophages infected with Orientia tsutsugamushi. Infect Immun 68 (2000) 594-602
190. Thap L.C., Supanaranond W., Treeprasertsuk S., Kitvatanachai S., Chinprasatsak S., and Phonrat B. Septic shock secondary to scrub typhus: characteristics and complications. Southeast Asian J Trop Med Public Health 33 (2002) 780-786
191. Economou M., Lithoxopoulou M., Aivazis V., Tsakalidis C., and Athanassiou-Metaxa M. Bartonella henselae: association with the development of transient lupus anticoagulant and asymptomatic prolongation of activated partial thromboplastin time. Scand J Infect Dis 35 (2003) 149
192. Vazquez-Boland J.A., Kuhn M., Berche P., Chakraborty T., Dominguez-Bernal G., Goebel W., et al. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14 (2001) 584-640
193. Drevets D.A., Leenen P.J., and Greenfield R.A. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev 17 (2004) 323-347
194. Drevets D.A., Sawyer R.T., Potter T.A., and Campbell P.A. Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun 63 (1995) 4268-4276
195. Drevets D.A. Dissemination of Listeria monocytogenes by infected phagocytes. Infect Immun 67 (1999) 3512-3517
196. Greiffenberg L., Sokolovic Z., Schnittler H.J., Spory A., Bockmann R., Goebel W., et al. Listeria monocytogenes-infected human umbilical vein endothelial cells: internalin-independent invasion, intracellular growth, movement, and host cell responses. FEMS Microbiol Lett 157 (1997) 163-170
197. Wilson S.L., and Drevets D.A. Listeria monocytogenes infection and activation of human brain microvascular endothelial cells. J Infect Dis 178 (1998) 1658-1666
198. Greiffenberg L., Goebel W., Kim K.S., Weiglein I., Bubert A., Engelbrecht F., et al. Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect Immun 66 (1998) 5260-5267
199. Parida S.K., Domann E., Rohde M., Muller S., Darji A., Hain T., et al. Internalin B is essential for adhesion and mediates the invasion of Listeria monocytogenes into human endothelial cells. Mol Microbiol 28 (1998) 81-93
200. Greiffenberg L., Goebel W., Kim K.S., Daniels J., and Kuhn M. Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: an electron microscopic study. Infect Immun 68 (2000) 3275-3279
201. Hertzig T., Weber M., Greiffenberg L., Holthausen B.S., Goebel W., Kim K.S., et al. Antibodies present in normal human serum inhibit invasion of human brain microvascular endothelial cells by Listeria monocytogenes. Infect Immun 71 (2003) 95-100
202. Krull M., Nost R., Hippenstiel S., Domann E., Chakraborty T., and Suttorp N. Listeria monocytogenes potently induces up-regulation of endothelial adhesion molecules and neutrophil adhesion to cultured human endothelial cells. J Immunol 159 (1997) 1970-1976
203. Drevets D.A. Listeria monocytogenes infection of cultured endothelial cells stimulates neutrophil adhesion and adhesion molecule expression. J Immunol 158 (1997) 5305-5313
204. Lopez S., Prats N., and Marco A.J. Expression of E-selectin, P-selectin, and intercellular adhesion molecule-1 during experimental murine listeriosis. Am J Pathol 155 (1999) 1391-1397
205. Schmeck B., Beermann W., van Laak V., Zahlten J., Opitz B., Witzenrath M., et al. Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification. J Immunol 175 (2005) 2843-2850
206. Opitz B., Puschel A., Beermann W., Hocke A.C., Forster S., Schmeck B., et al. Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells. J Immunol 176 (2006) 484-490
207. Sibelius U., Rose F., Chakraborty T., Darji A., Wehland J., Weiss S., et al. Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells. Infect Immun 64 (1996) 674-676
208. Sibelius U., Chakraborty T., Krogel B., Wolf J., Rose F., Schmidt R., et al. The listerial exotoxins listeriolysin and phosphatidylinositol-specific phospholipase C synergize to elicit endothelial cell phosphoinositide metabolism. J Immunol 157 (1996) 4055-4060
209. Drevets D.A. Listeria monocytogenes virulence factors that stimulate endothelial cells. Infect Immun 66 (1998) 232-238
210. Schwarzer N., Nost R., Seybold J., Parida S.K., Fuhrmann O., Krull M., et al. Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-κB activation, and E-selectin expression in human endothelial cells. J Immunol 161 (1998) 3010-3018
211. Bubert A., Sokolovic Z., Chun S.K., Papatheodorou L., Simm A., and Goebel W. Differential expression of Listeria monocytogenes virulence genes in mammalian host cells. Mol Gen Genet 261 (1999) 323-336
212. Kayal S., Lilienbaum A., Poyart C., Memet S., Israel A., and Berche P. Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-κB and upregulation of adhesion molecules and chemokines. Mol Microbiol 31 (1999) 1709-1722
213. Rose F., Zeller S.A., Chakraborty T., Domann E., Machleidt T., Kronke M., et al. Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect Immun 69 (2001) 897-905
214. Kayal S., Lilienbaum A., Join-Lambert O., Li X., Israel A., and Berche P. Listeriolysin O secreted by Listeria monocytogenes induces NF-κB signalling by activating the IκB kinase complex. Mol Microbiol 44 (2002) 1407-1419
215. Han Y.W., Shi W., Huang G.T., Kinder Haake S., Park N.H., Kuramitsu H., et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 68 (2000) 3140-3146
216. Han Y.W., Redline R.W., Li M., Yin L., Hill G.B., and McCormick T.S. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 72 (2004) 2272-2279
217. Quinn F.D., Weyant R.S., Worley M.J., White E.H., Utt E.A., and Ades E.A. Human microvascular endothelial tissue culture cell model for studying pathogenesis of Brazilian purpuric fever. Infect Immun 63 (1995) 2317-2322
218. Denecker G., Totemeyer S., Mota L.J., Troisfontaines P., Lambermont I., Youta C., et al. Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Infect Immun 70 (2002) 3510-3520
219. Scollard D.M., Lathrop G.W., and Truman R.W. Infection of distal peripheral nerves by M. leprae in infected armadillos; an experimental model of nerve involvement in leprosy. J Lepr Other Mycobact Dis 64 (1996) 146-151
220. Scollard D.M., McCormick G., and Allen J.L. Localization of Mycobacterium leprae to endothelial cells of epineurial and perineurial blood vessels and lymphatics. Am J Pathol 154 (1999) 1611-1620
221. Toscano V., Bontadini A., Falsone G., Conte R., Fois F., Fabiani A., et al. Thrombotic thrombocytopenic purpura associated with primary tuberculosis. Infection 23 (1995) 58-59
222. Scollard D.M. Association of Mycobacterium leprae with human endothelial cells in vitro. Lab Invest 80 (2000) 663-669
223. Scollard D.M. Endothelial cells and the pathogenesis of lepromatous neuritis: insights from the armadillo model. Microbes Infect 2 (2000) 1835-1843
224. Dugue C., Perraut R., Youinou P., and Renaudineau Y. Effects of anti-endothelial cell antibodies in leprosy and malaria. Infect Immun 72 (2004) 301-309
225. Plotkowski M.C., Saliba A.M., Pereira S.H., Cervante M.P., and Bajolet-Laudinat O. Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells. Infect Immun 62 (1994) 5456-5463
226. Britigan B.E., Rasmussen G.T., and Cox C.D. Pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury. Am J Physiol 266 (1994) L192-L198
227. Darveau R.P., Cunningham M.D., Bailey T., Seachord C., Ratcliffe K., Bainbridge B., et al. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun 63 (1995) 1311-1317
228. De Assis M.C., Saliba A.M., Vidipo L.A., De Salles J.B., and Plotkowski M.C. Pseudomonas aeruginosa-induced production of free radicals by IFNγ plus TNFα-activated human endothelial cells: mechanism of host defense or of bacterial pathogenesis?. Immunol Cell Biol 82 (2004) 383-392
229. Saliba A.M., Filloux A., Ball G., Silva A.S., Assis M.C., and Plotkowski M.C. Type III secretion-mediated killing of endothelial cells by Pseudomonas aeruginosa. Microb Pathog 33 (2002) 153-166
230. Bourke W.J., O'Connor C.M., FitzGerald M.X., and McDonnell T.J. Pseudomonas aeruginosa exotoxin A induces pulmonary endothelial cytotoxicity: protection by dibutyryl-cAMP. Eur Respir J 7 (1994) 1754-1758
231. Saliba A.M., Nascimento D.O., Silva M.C., Assis M.C., Gayer C.R., Raymond B., et al. Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU. Cell Microbiol 7 (2005) 1811-1822
232. Saliba A.M., de Assis M.C., Nishi R., Raymond B., Marques Ede A., Lopes U.G., et al. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU. Microbes Infect 8 2 (Feb 2006) 450-459
233. Britigan B.E., Roeder T.L., Rasmussen G.T., Shasby D.M., McCormick M.L., and Cox C.D. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. J Clin Invest 90 (1992) 2187-2196
234. Komori Y., Nonogaki T., and Nikai T. Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39 (2001) 1327-1332
235. DeWitte J.J., Cox C.D., Rasmussen G.T., and Britigan B.E. Assessment of structural features of the Pseudomonas siderophore pyochelin required for its ability to promote oxidant-mediated endothelial cell injury. Arch Biochem Biophys 393 (2001) 236-244
236. Muller M. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Radic Biol Med 33 (2002) 1527-1533
237. Kipnis E., Guery B.P., Tournoys A., Leroy X., Robriquet L., Fialdes P., et al. Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock 21 (2004) 444-451
238. Martinez J.J., Seveau S., Veiga E., Matsuyama S., and Cossart P. Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. Cell 123 (2005) 1013-1023
239. Walker D.H. Targeting Rickettsia. N Engl J Med 354 (2006) 1418-1420
240. Zysk G., Schneider-Wald B.K., Hwang J.H., Bejo L., Kim K.S., Mitchell T.J., et al. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 69 (2001) 845-852
241. Radin J.N., Orihuela C.J., Murti G., Guglielmo C., Murray P.J., and Tuomanen E.I. β-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun 73 (2005) 7827-7835
242. Hoffmann I., Eugene E., Nassif X., Couraud P.O., and Bourdoulous S. Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis. J Cell Biol 155 (2001) 133-143
243. Eugene E., Hoffmann I., Pujol C., Couraud P.O., Bourdoulous S., and Nassif X. Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J Cell Sci 115 (2002) 1231-1241
244. Rohde M., Muller E., Chhatwal G.S., and Talay S.R. Host cell caveolae act as an entry-port for group A Streptococci. Cell Microbiol 5 (2003) 323-342
245. Prasadarao N.V., Wass C.A., and Kim K.S. Endothelial cell GlcNAc β1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect Immun 64 (1996) 154-160
246. Prasadarao N.V., Wass C.A., Stins M.F., Shimada H., and Kim K.S. Outer membrane protein A-promoted actin condensation of brain microvascular endothelial cells is required for Escherichia coli invasion. Infect Immun 67 (1999) 5775-5783
247. Reddy M.A., Prasadarao N.V., Wass C.A., and Kim K.S. Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J Biol Chem 275 (2000) 36769-36774
248. Sukumaran S.K., and Prasadarao N.V. Regulation of protein kinase C in Escherichia coli K1 invasion of human brain microvascular endothelial cells. J Biol Chem 277 (2002) 12253-12262
249. Rudrabhatla R.S., Selvaraj S.K., and Prasadarao N.V. Role of Rac1 in Escherichia coli K1 invasion of human brain microvascular endothelial cells. Microbes Infect 8 (2006) 460-469
250. Puolakkainen M., Kuo C.C., and Campbell L.A. Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infect Immun 73 (2005) 4620-4625
251. Bolovan-Fritts C.A., and Wiedeman J.A. Mapping the viral genetic determinants of endothelial cell tropism in human cytomegalovirus. J Clin Virol 25 (2002) S97-S109
252. Ryckman B.J., Jarvis M.A., Drummond D.D., Nelson J.A., and Johnson D.C. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80 (2006) 710-722
253. Feldmann A., Schafer M.K., Garten W., and Klenk H.D. Targeted infection of endothelial cells by avian influenza virus A/FPV/Rostock/34 (H7N1) in chicken embryos. J Virol 74 (2000) 8018-8027
254. Negrete O.A., Levroney E.L., Aguilar H.C., Bertolotti-Ciarlet A., Nazarian R., Tajyar S., et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436 (2005) 401-405
255. Bella J., and Rossmann M.G. Rhinoviruses and their ICAM receptors. J Struct Biol 128 (1999) 69-74
256. Krishnan H.H., Sharma-Walia N., Streblow D.N., Naranatt P.P., and Chandran B. Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells. J Virol 80 (2006) 1167-1180
257. Chi D., Henry J., Kelley J., Thorpe R., Smith J.K., and Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium 7 (2000) 223-242
258. Liu N.Q., Lossinsky A.S., Popik W., Li X., Gujuluva C., Kriederman B., et al. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 76 (2002) 6689-6700
259. Argyris E.G., Acheampong E., Nunnari G., Mukhtar M., Williams K.J., and Pomerantz R.J. Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts. J Virol 77 (2003) 12140-12151
260. Bobardt M.D., Salmon P., Wang L., Esko J.D., Gabuzda D., Fiala M., et al. Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol 78 (2004) 6567-6584
261. Huang B., Dong Y., Mai W., and Li Y. Effect of Chlamydia pneumoniae infection and hyperlipidaemia on the expression of PPARγ, P50 and c-Fos in aortic endothelial cells in C57bL/6J mice. Acta Cardiol 60 (2005) 43-49
262. Rydkina E., Silverman D.J., and Sahni S.K. Similarities and differences in host cell signaling following infection with different Rickettsia species. Ann N Y Acad Sci 1063 (2005) 203-206